A nurse is providing education to a client with chronic asthma who has been prescribed the anti-leukotriene modifier montelukast. The nurse evaluates the client's understanding of the medication's purpose. Which statement by the client indicates understanding of the medication?

A. "I will take this medication every time I have an acute asthma attack.": Montelukast is not a rescue medication and is ineffective during acute asthma attacks. Short-acting bronchodilators, such as albuterol, are the preferred treatment for immediate relief. B. "This medication will help to open my airways immediately when I feel short of breath.": Montelukast works by blocking leukotriene receptors, reducing airway inflammation over time. It does not provide rapid bronchodilation, so it cannot relieve acute shortness of breath. C. "I will continue to take my other asthma medications as this drug works to prevent future attacks.": Montelukast is used as a maintenance medication to help prevent asthma exacerbations and control chronic symptoms. It is often prescribed alongside inhaled corticosteroids and bronchodilators as part of long-term asthma management. D. "I should stop taking this medication when my asthma symptoms improve.": Stopping montelukast abruptly may increase the risk of future asthma exacerbations. The medication should be taken consistently, even when the client is asymptomatic.